Mutation in the leucine-rich repeat C-flanking region of platelet glycoprotein Ibβ impairs assembly of von Willebrand factor receptor

Summary

We describe a syndrome of thrombocytopenia, bleeding episodes, congenital heart disease and facial dysmorphism in a newborn infant, and trace the cause to mutations on chromosome 22 that involve the gene for platelet glycoprotein Ibβ (GPIbβ, Human Genome Organisation gene symbol GPIBB), a critical component of the von Willebrand factor (vWF) receptor. Fluorescence in situ hybridization in transformed lymphoblasts revealed hemizygous microdeletion of 22q11.2 containing the GP1BB locus. DNA sequencing revealed a C to T transition in the patient’s remaining GP1BB allele, predicting a novel proline to serine substitution (Pro96Ser) in the carboxyterminal flanking domain of a leucine-rich repeat. We characterized the mutant GP1BB allele by expression in a cell line (CHOαIX) that stably expresses two other components of the vWF receptor, GPIbα and GPIX. Flow cytometry and confocal imaging of transfected CHOαIX cells demonstrated that P96S GPIbβ abrogates surface assembly of the complex, consistent with platelet flow cytometry studies in the patient. Based on sequence homology to the known crystal structures of two other leucine-rich repeat proteins, the human Nogo receptor and GPIbα, we propose a new structural model of GPIbβ. The model refutes earlier assumptions about cysteine-cysteine interactions in the amino-terminal region of GPIbβ, and predicts a hydrophobic patch the burial of which may contribute to proper conformation of the fully assembled vWF receptor complex.

Keywords

Genetic diseases - platelets - structural biology

• References

• 1 Sprintzen RJ. Velocardiofacial syndrome. Otolaryngol Clin North Am 2000; 33: 1217-40.
• 2 Ryan AK, Goodship JA, Wilson DI. et al. Spectrum of clinical features associated with interstitial chromosome 22q11 deletions: a European collaborative study. J Med Genet 1997; 34: 798-804.
• 3 Van Geet C, Devriendt K, Eyskens B. et al. Velocardiofacial syndrome patients with a heterozygous chromosome 22q11 deletion have giant platelets. Pediatr Res 1998; 44: 607-11.
• 4 Yagi M, Edelhoff S, Disteche CM. et al. Structural characterization and chromosomal location of the gene encoding human platelet glycoprotein Ib beta. J Biol Chem 1994; 269: 17424-7.
• 5 Lopez JA, Andrews RK, Afshar-Kharghan V. et al. Bernard-Soulier syndrome. Blood 1998; 91: 4397-418.
• 6 Ludlow LB, Schick BP, Budarf ML. et al. Identification of a mutation in a GATAbinding site of the platelet glycoprotein Ibbeta promoter resulting in the Bernard-Soulier syndrome. J Biol Chem 1996; 271: 22076-80.
• 7 Kenny D, Morateck PA, Gill JC. et al. The critical interaction of glycoprotein (GP) IBbeta with GPIX-a genetic cause of Bernard-Soulier syndrome. Blood 1999; 93: 2968-75.
• 8 Kunishima S, Tomiyama Y, Honda S. et al. Homozygous Pro74-->Arg mutation in the platelet glycoprotein Ibbeta gene associated with Bernard-Soulier syndrome. Thromb Haemost 2000; 84: 112-7.
• 9 Moran N, Morateck PA, Deering A. et al. Surface expression of glycoprotein Ib alpha is dependent on glycoprotein I-Ib beta: evidence from a novel mutation causing Bernard-Soulier syndrome. Blood 2000; 96: 532-9.
• 10 Kurokawa Y, Ishida F, Kamijo T. et al. A missense mutation (Tyr88 to Cys) in the platelet membrane glycoprotein Ibβ gene affects GPIb/IX complex expression – Bernard-Soulier syndrome in the homozygous form and giant platelets in the heterozygous form. Thromb Haemost 2001; 86: 1249-56.
• 11 Hillmann A, Nurden A, Nurden P. et al. A novel hemizygous Bernard-Soulier syndrome (BSS) mutation in the amino terminal domain of glycoprotein (GP)Ibβ – platelet characterization and transfection studies. Thromb Haemost 2002; 88: 1026-32.
• 12 Strassel C, Pasquet JM, Alessi MC. et al. A novel missense mutation shows that GPIbβ has a dual role in controlling the processing and stability of the platelet GPIb-IX adhesion receptor. Biochemistry 2003; 42: 4452-62.
• 13 Peters M, Heijboer H. Treatment of a patient with Bernard-Soulier syndrome and recurrent nosebleeds with recombinant Factor VIIa. Thromb Haemost 1998; 80: 352.
• 14 Locatelli F, Rossi G, Balduini C. Hematopoietic stem-cell transplantation for the Bernard-Soulier syndrome. Ann Intern Med 2003; 138: 79.
• 15 Kunishima S, Naoe T, Kamiya T. et al. Novel heterozygous missense mutation in the platelet glycoprotein Ib beta gene associated with isolated giant platelet disorder. Am J Hematol 2001; 68: 249-55.
• 16 Jackson SP, Mistry N, Yuan Y. Platelets and the injured vessel wall-”rolling into action”: focus on glycoprotein Ib/V/IX and the platelet cytoskeleton. Trends Cardiovasc Med 2000; 10: 192-7.
• 17 Kobe B, Kajava AV. The leucine-rich repeat as a protein recognition motif. Curr Opin Struct Biol 2001; 11: 725-32.
• 18 Hickey MJ, Hagen FS, Yagi M. et al. Human platelet glycoprotein V: characterization of the polypeptide and the related Ib-V-IX receptor system of adhesive, leucine-rich glycoproteins. Proc Natl Acad Sci USA 1993; 90: 8327-31.
• 19 Lopez JA, Weisman S, Sanan DA. et al. Glycoprotein (GP) Ibb is the critical subunit linking GP Iba and GP IX in the GP Ib-IX complex. J Biol Chem 1994; 269: 23716-21.
• 20 Roth GJ, Yagi M, Bastian LS. The platelet glycoprotein Ib-V-IX system: regulation of gene expression. Stem Cells 1996; 14 (Suppl. 01) 188-93.
• 21 Andrews RK, Gardiner EE, Shen Y. et al. Glycoprotein Ib-IX-V. Int J Biochem Cell Biol 2003; 35: 1170-4.
• 22 Berndt MC, Shen Y, Dopheide SM. et al. The vascular biology of the GPIb-IX-V complex. Thromb Haemost 2001; 86: 178-88.
• 23 Huizinga EG, Tsuji S, Romijn RA. et al. Structures of glycoprotein Ib alpha and its complex with von Willebrand factor A1 domain. Science 2002; 297: 1176-9.
• 24 Uff S, Clemetson JM, Harrison T. et al. Crystal structure of the platelet glycoprotein Ib(alpha) N-terminal domain reveals an unmasking mechanism for receptor activation. J Biol Chem 2002; 277: 35657-63.
• 25 Kunishima S, Kamiya T, Saito H. Genetic abnormalities of Bernard-Soulier syndrome. Int J Hematol 2002; 76: 319-27.
• 26 Nakagawa M, Okuno M, Okamoto H. et al. Bernard-Soulier syndrome associated with 22q11.2 microdeletion. Am J Med Genet 2001; 99: 286-8.
• 27 Lascone MR, Sacchelli M, Vittorini S. et al. Complex conotruncal heart defect, severe bleeding disorder and 22q11 deletion: a new case of Bernard-Soulier syndrome and of 22q11 deletion syndrome?. Ital Heart J 2001; 02: 475-7.
• 28 Rivera CE, Villagra J, Riordan M. et al. Identification of a new mutation in platelet glycoprotein IX (GPIX) in a patient with Bernard-Soulier syndrome. Br J Haematol 2001; 112: 105-8.
• 29 Kallioniemi A, Kallioniemi OP, Waldman FM. et al. Detection of retinoblastoma gene copy number in metaphase chromosomes and interphase nuclei by fluorescence in situ hybridization. Cytogenet Cell Genet 1992; 60: 190-3.
• 30 Matyakhina L, Pack S, Kirschner LS. et al. Chromosome 2 (2p16) abnormalities in Carney complex tumours. J Med Genet 2003; 40: 268-77.
• 31 Stevens B, Porta S, Haak LL. et al. Adenosine: a neuron-glial transmitter promoting myelination in the CNS in response to action potentials. Neuron 2002; 36: 855-68.
• 32 Levitt M. Accurate modeling of protein conformation by automatic segment matching. J Mol Biol 1992; 226: 507-33.
• 33 Brooks BR, Bruccoleri RE, Olafson BD. et al. CHARMM: A program for macromolecular energy, minimization, and dynamics calculations. J Comput Chem 1983; 04: 187-217.
• 34 Lazaridis T, Karplus M. Effective energy function for proteins in solution. Prot Struct Func Genet 1999; 35: 133-52.
• 35 Letunic I, Goodstadt L, Dickens NJ. et al. Recent improvements to the SMART domainbased sequence annotation resource. Nucleic Acids Res 2002; 30: 242-4.
• 36 Bateman A, Birney E, Cerruti L. et al. The Pfam protein families database. Nucleic Acids Res 2002; 30: 276-80.
• 37 He XL, Bazan JF, McDermott G. et al. Structure of the Nogo receptor ectodomain: a recognition module implicated in myelin inhibition. Neuron 2003; 38: 177-85.
• 38 Barton WA, Liu BP, Tzvetkova D. et al. Structure and axon outgrowth inhibitor binding of the Nogo-66 receptor and related proteins. EMBO J 2003; 22: 3291-302.
• 39 Dong JF, Gao S, Lopez JA. Synthesis, assembly, and intracellular transport of the platelet glycoprotein Ib-IX-V complex. J Biol Chem 1998; 273: 31449-54.
• 40 Lopez JA. The platelet glycoprotein Ib-IX complex. Blood Coag Fibrinol 1994; 05: 97-119.
• 41 Kenny D, Morateck PA, Montgomery RR. The cysteine knot of platelet glycoprotein Ib beta (GPIb beta) is critical for the interaction of GPIb beta with GPIX. Blood 2002; 99: 4428-33.
• 42 González-Manchón C, Butta N, Iruín G. et al. Disruption of the Cys5-Cys7 disulfide bridge in the platelet glycoprotein Ibβ prevents the normal maturation and surface exposure of GPIb-IX complexes. Thromb Haemost 2003; 90: 456-64.
• 43 Neame PJ, Choi HU, Rosenberg LC. The primary structure of the core protein of the small, lecine-rich proteoglycan (PGI) from bovine articular cartilage. J Biol Chem 1988; 264: 8653-61.
• 44 Kato T, Kosaka K, Kimura M. et al. Thrombocytopenia in patients with 22q11.2 deletion syndrome and its association with glycoprotein Ib-beta. Genet Med 2003; 05: 113-9.
• 45 Kunishima S, Lopez JA, Kobayashi S. et al. Missense mutations of the glycoprotein (GP) Ib beta gene impairing the GPIb alpha/beta disulfide linkage in a family with giant platelet disorder. Blood 1997; 89: 2404-12.